← Back to Clinical Trials
Recruiting NCT06181097

Routine Use of Negative Pressure Wound Therapy THR TKR RCT

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Knee Arthropathy
Sponsor Chinese University of Hong Kong
Study Type INTERVENTIONAL
Phase N/A
Enrollment 82
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2023-12-11
Completion 2025-12-10
Interventions
negative pressure wound therapystandard dressing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Negative pressure wound therapy (NPWT) for post total joint arthroplasty incisions has demonstrated benefits in reducing wound complications. A prospective randomized trial will be conducted including 40 patients who will undergo total knee and total hip arthroplasty. The number of wound complications within 21 days will be recorded. As well, the aesthetic appearance and quality of scarring of the scar will be assessed.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing total knee or total hip arthroplasty at Prince of Wales Hospital, Hong Kong. Exclusion Criteria: * Patients using steroid, or other immune modulators that is known to affect wound healing, prior surgery to the knee or hip, skin condition such as eczema that would result in poor healing or widen scars, patients with a known significant history of hypertrophic scarring or keloid.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}